Protalix BioTherapeutics, Inc.
PLX- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001006281
No open-market purchases or sales by Protalix BioTherapeutics, Inc. insiders were filed in the last 90 days; 101 institutions reported holding it in 13F filings for Q2 2026, worth $33.7M in total; no superinvestor holds it.
13F holders, Q1 2023
Institutional positions in Protalix BioTherapeutics, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 34
- +8 vs. Q4 2022
- Shares held
- 2.94M
- −630.2K (−17.7%) vs. Q4 2022
- Total value
- $6.15M
- +$1.28M (+26.2%) vs. Q4 2022
- New holders
- 11
- 7 more added
- Sold out
- 3
- 7 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PLX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 101 | $33.7M |
| Q1 2026 | 100 | $36.6M |
| Q4 2025 | 83 | $26.8M |
| Q3 2025 | 77 | $31.0M |
| Q2 2025 | 63 | $17.6M |
| Q1 2025 | 63 | $21.0M |
| Q4 2024 | 46 | $8.40M |
| Q3 2024 | 45 | $3.53M |
| Q2 2024 | 66 | $6.60M |
| Q1 2024 | 64 | $12.4M |
| Q4 2023 | 66 | $18.1M |
| Q3 2023 | 61 | $15.2M |
| Q2 2023 | 66 | $17.9M |
| Q1 2023 | 34 | $6.15M |
| Q4 2022 | 26 | $4.87M |
| Q3 2022 | 27 | $3.70M |
| Q2 2022 | 30 | $1.30M |
| Q1 2022 | 32 | $1.29M |
| Q4 2021 | 31 | $2.52M |
| Q3 2021 | 35 | $5.91M |
| Q2 2021 | 33 | $8.71M |
| Q1 2021 | 38 | $39.4M |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Protalix BioTherapeutics, Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Renaissance Technologies LLC | 1,209,750 | $2.54M | 0.00% | +985,147+438.6% | Added |
| Meitav Dash Investments Ltd | 244,332 | $493.6K | 0.01% | −150−0.1% | Reduced |
| Citadel Advisors LLC | 211,548 | $444.3K | 0.00% | +87,241+70.2% | Added |
| Two Sigma Investments, LP | 194,094 | $407.6K | 0.00% | +183,968+1,816.8% | Added |
| Connor, Clark & Lunn Investment Management Ltd. | 158,703 | $333.3K | 0.00% | +158,703 | New |
| Marshall Wace, LLP | 150,358 | $315.8K | 0.00% | +150,358 | New |
| Bridgeway Capital Management, LLC | 133,790 | $281.0K | 0.01% | 00.0% | Unchanged |
| BlackRock Inc. | 116,143 | $243.9K | 0.00% | +14,250+14.0% | Added |
| Millennium Management LLC | 86,698 | $182.0K | 0.00% | +86,698 | New |
| Morgan Stanley | 82,176 | $172.6K | 0.00% | +73,959+900.1% | Added |
| Commonwealth Equity Services, LLC | 50,100 | $105.0K | 0.00% | 00.0% | Unchanged |
| Jane Street Group, LLC | 39,665 | $83.3K | 0.00% | −52,554−57.0% | Reduced |
| XTX Topco Ltd | 34,064 | $71.5K | 0.01% | +34,064 | New |
| IHT Wealth Management, LLC | 26,800 | $56.3K | 0.00% | 00.0% | Unchanged |
| Capital Performance Advisors LLP | 25,974 | $54.5K | 0.03% | 00.0% | Unchanged |
| CIBC World Markets Inc. | 25,000 | $52.0K | 0.00% | −11,000−30.6% | Reduced |
| Two Sigma Securities, LLC | 20,760 | $43.6K | 0.00% | +20,760 | New |
| Two Sigma Advisers, LP | 19,900 | $41.8K | 0.00% | −700−3.4% | Reduced |
| Sculptor Capital LP | 19,100 | $40.1K | 0.00% | +19,100 | New |
| Aptus Capital Advisors, LLC | 16,010 | $33.6K | 0.00% | +16,010 | New |
| Lido Advisors, LLC | 15,554 | $32.7K | 0.00% | +15,554 | New |
| Altshuler Shaham Ltd | 12,142 | $25.5K | 0.00% | −336−2.7% | Reduced |
| HRT Financial LP | 10,309 | $21.0K | 0.00% | +10,309 | New |
| TD Waterhouse Canada Inc. | 6,000 | $13.2K | 0.00% | 00.0% | Unchanged |
| National Bank of Canada | 6,100 | $12.7K | 0.00% | 00.0% | Unchanged |
| Federated Hermes, Inc. | 5,761 | $12.1K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 4,691 | $9.85K | 0.00% | +4,571+3,809.2% | Added |
| Truvestments Capital LLC | 3,880 | $8.15K | 0.00% | +3,880 | New |
| Psagot Value Holdings Ltd. / (Israel) | 3,744 | $7.00K | 0.00% | −2,256−37.6% | Reduced |
| Barclays PLC | 2,000 | $4.20K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 1,602 | $3.00K | 0.00% | +1,602 | New |
| Advisor Group Holdings, Inc. | 601 | $1.26K | 0.00% | +101+20.2% | Added |
| Federation des caisses Desjardins du Quebec | 250 | $525 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 39 | $82 | 0.00% | −2,928−98.7% | Reduced |
| Highbridge Capital Management LLC | 0 | $0 | 0.00% | −2,413,487−100.0% | Sold out |
| Smith, Salley & Associates | 0 | $0 | 0.00% | −12,048−100.0% | Sold out |
| Ten Capital Wealth Advisors, LLC | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |